Mahesh Krishnan serves as Executive at CHINOOK THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Mahesh Krishnan has executed 4 insider transactions totaling $21.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 25, 2024 involved receiving (via award) 6,501 shares valued at $0.
Mahesh Krishnan currently holds 6,501 shares of CHINOOK THERAPEUTICS, INC. (KDNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mahesh Krishnan has been a net seller of KDNY stock. They have purchased $0 and sold $21.3K worth of shares.
Mahesh Krishnan's most recent insider trade was on Apr 25, 2024, when they sold 6,501 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 4, 2023 | KDNY | $21.3K | Sale | 924 | $23.01 | Planned |
| Apr 1, 2023 | KDNY | $0 | Option Exercise | 2,199 | $N/A | Planned |